Carsten Utoft N.
- Country
- Denmark
- Department
- Department of Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 8 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating Chronic Lymphocytic Leukemia (CLL) and its variants, including Small Lymphocytic Lymphoma (SLL). Their expertise extends to managing complex cases and exploring innovative therapeutic approaches for these conditions.
- CLL Treatment Strategies
- Management of Treatment-Naive Patients
- Richter Transformation
Novel Therapeutic Combinations
The investigator focuses on evaluating combination therapies involving targeted agents such as BTK inhibitors, BCL2 inhibitors, and monoclonal antibodies. Their work encompasses both conventional and emerging treatment approaches.
- BTK Inhibitor-Based Regimens
- Venetoclax Combinations
- Immunotherapy Applications
Patient-Centered Care
Their clinical interests include developing treatment strategies for previously untreated patients and those with coexisting medical conditions. The investigator's work emphasizes safety and efficacy in vulnerable patient populations.
- Treatment Optimization
- Disease Progression Management
- Infection Prevention Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.